The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 16, 2024

Filed:

May. 27, 2022
Applicants:

Massachusetts Institute of Technology, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Novo Nordisk A/s, Bagsvaerd, DK;

Inventors:

Carlo Giovanni Traverso, Newton, MA (US);

Alex G. Abramson, St. Louis, MO (US);

Ester Caffarel Salvador, Cambridge, MA (US);

Niclas Roxhed, Bromma, SE;

Minsoo Khang, Boston, MA (US);

Taylor Bensel, Walpole, MA (US);

Robert S. Langer, Newton, MA (US);

Jorrit Jeroen Water, Bagsvaerd, DK;

Morten Revsgaard Frederiksen, Bagsvaerd, DK;

Bo Uldall Kristiansen, Bagsvaerd, DK;

Mikkel Oliver Jespersen, Bagsvaerd, DK;

Mette Poulsen, Bagsvaerd, DK;

Peter Herskind, Bagsvaerd, DK;

Brian Jensen, Bagsvaerd, DK;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61B 5/145 (2006.01); A61B 10/02 (2006.01); A61J 3/07 (2006.01); A61K 9/00 (2006.01); A61K 38/28 (2006.01); A61M 5/142 (2006.01); A61M 5/145 (2006.01); A61M 5/158 (2006.01); A61M 5/20 (2006.01); A61M 5/32 (2006.01); A61M 31/00 (2006.01); A61M 37/00 (2006.01); A61N 1/32 (2006.01); A61N 1/36 (2006.01); A61B 10/06 (2006.01); A61N 1/05 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4808 (2013.01); A61B 5/14503 (2013.01); A61B 5/14539 (2013.01); A61B 10/02 (2013.01); A61J 3/07 (2013.01); A61K 9/0002 (2013.01); A61K 9/0012 (2013.01); A61K 9/0021 (2013.01); A61K 9/0065 (2013.01); A61K 9/0092 (2013.01); A61K 9/4866 (2013.01); A61K 38/28 (2013.01); A61M 5/14276 (2013.01); A61M 5/1454 (2013.01); A61M 5/158 (2013.01); A61M 5/2033 (2013.01); A61M 5/329 (2013.01); A61M 5/3295 (2013.01); A61M 31/002 (2013.01); A61M 37/0015 (2013.01); A61M 37/0069 (2013.01); A61N 1/325 (2013.01); A61N 1/36007 (2013.01); A61B 2010/0208 (2013.01); A61B 10/0233 (2013.01); A61B 10/06 (2013.01); A61M 2005/14284 (2013.01); A61M 2005/1581 (2013.01); A61M 2005/1585 (2013.01); A61M 2037/0023 (2013.01); A61M 2037/0053 (2013.01); A61M 2205/0238 (2013.01); A61M 2205/21 (2013.01); A61M 2210/1053 (2013.01); A61M 2210/106 (2013.01); A61N 1/0509 (2013.01);
Abstract

Self-righting articles, such as self-righting capsules for administration to a subject, are generally provided. In some embodiments, the self-righting article may be configured such that the article may orient itself relative to a surface (e.g., a surface of a tissue of a subject). The self-righting articles described herein may comprise one or more tissue engaging surfaces configured to engage (e.g., interface with, inject into, anchor) with a surface (e.g., a surface of a tissue of a subject). In some embodiments, the self-righting article may have a particular shape and/or distribution of density (or mass) which, for example, enables the self-righting behavior of the article. In some embodiments, the self-righting article may comprise a tissue interfacing component and/or a pharmaceutical agent (e.g., for delivery of the active pharmaceutical agent to a location internal of the subject). In some cases, upon contact of the tissue with the tissue engaging surface of the article, the self-righting article may be configured to release one or more tissue interfacing components. In some cases, the tissue interfacing component is associated with a self-actuating component. For example, the self-righting article may comprise a self-actuating component configured, upon exposure to a fluid, to release the tissue interfacing component from the self-righting article. In some cases, the tissue interfacing component may comprise and/or be associated with the pharmaceutical agent (e.g., for delivery to a location internal to a subject).


Find Patent Forward Citations

Loading…